Home › Psoriatic Arthritis › Maryland
Psoriatic Arthritis clinical trials in Maryland
7 studies for Psoriatic Arthritis are looking for participants at sites in Maryland.
Cities in Maryland
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
- Klein And Associates M D P A, Hagerstown
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06807424Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Klein & Associates, M.D., P.A., Hagerstown
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT06671483Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
- Johns Hopkins Bayview Medical Center - Johns Hopkins Asthma & Allergy Center ( Site 5132), Baltimore
- Arthritis and Rheumatism Associates - Rockville ( Site 5127), Rockville
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 14, 2026 · NCT07486960Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Baltimore
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- Johns Hopkins Hospital, Baltimore
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06671496Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Klein and Associates, M.D., P.A., Hagerstown
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07286058From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.